PT1781272T - Utilização de compostos ativos no recetor sigma para o tratamento de alodinia mecânica - Google Patents

Utilização de compostos ativos no recetor sigma para o tratamento de alodinia mecânica

Info

Publication number
PT1781272T
PT1781272T PT57699720T PT05769972T PT1781272T PT 1781272 T PT1781272 T PT 1781272T PT 57699720 T PT57699720 T PT 57699720T PT 05769972 T PT05769972 T PT 05769972T PT 1781272 T PT1781272 T PT 1781272T
Authority
PT
Portugal
Prior art keywords
treatment
mechanical allodynia
sigma receptor
compounds active
compounds
Prior art date
Application number
PT57699720T
Other languages
English (en)
Inventor
M Baeyens Cabrera José
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/902,272 external-priority patent/US20060019968A1/en
Priority claimed from US10/902,273 external-priority patent/US20060019969A1/en
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of PT1781272T publication Critical patent/PT1781272T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7125—Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT57699720T 2004-07-24 2005-07-25 Utilização de compostos ativos no recetor sigma para o tratamento de alodinia mecânica PT1781272T (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP04017561 2004-07-24
EP04017562 2004-07-24
US10/902,272 US20060019968A1 (en) 2004-07-24 2004-07-30 Use of compounds active on the sigma receptor for the treatment of neuropathic pain
US10/902,273 US20060019969A1 (en) 2004-07-24 2004-07-30 Use of compounds active on the sigma receptor for the treatment of allodynia
EP04020376 2004-08-27

Publications (1)

Publication Number Publication Date
PT1781272T true PT1781272T (pt) 2017-12-11

Family

ID=56290707

Family Applications (1)

Application Number Title Priority Date Filing Date
PT57699720T PT1781272T (pt) 2004-07-24 2005-07-25 Utilização de compostos ativos no recetor sigma para o tratamento de alodinia mecânica

Country Status (7)

Country Link
EP (1) EP1781272B1 (pt)
JP (1) JP2008507489A (pt)
CA (1) CA2573122A1 (pt)
ES (1) ES2651021T3 (pt)
MX (1) MX2007000793A (pt)
PT (1) PT1781272T (pt)
WO (1) WO2006010587A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2402789T3 (es) 2006-11-20 2013-05-08 President And Fellows Of Harvard College Métodos, composicones y kits para tratar dolor y prurito
WO2008096755A1 (ja) * 2007-02-07 2008-08-14 Nippon Suisan Kaisha, Ltd. バニロイド受容体（ｖｒ１）阻害剤及びその用途
DK2254579T3 (en) * 2008-02-18 2018-04-09 Esteve Labor Dr Use of Compounds Binding to the Sigmar Receptor Ligands for the Treatment of Neuropathic Pain Developed by Chemotherapy
EP2090311A1 (en) * 2008-02-18 2009-08-19 Laboratorios Del. Dr. Esteve, S.A. Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy
CN101970427A (zh) 2008-02-29 2011-02-09 Vm生物医药公司 治疗疼痛症状及其它失调的方法
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
JP6205133B2 (ja) 2009-07-10 2017-09-27 プレジデント アンド フェローズ オブ ハーバード カレッジ 抗炎症剤としての恒久的に荷電したナトリウムおよびカルシウムチャンネルブロッカー
EP2353591A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
EP2353598A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for use in the prevention and/or treatment of postoperative pain
EP2388005A1 (en) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
EP2415471A1 (en) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in opioid-induced hyperalgesia
EP2524694A1 (en) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in diabetes type-2 associated pain
SG11201604480PA (en) 2013-12-17 2016-07-28 Esteve Labor Dr SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS
RU2018107695A (ru) 2015-08-03 2019-09-05 Президент Энд Феллоуз Оф Гарвард Колледж Заряженные блокаторы ионных каналов и способы их применения
EP3415143A1 (en) * 2017-06-16 2018-12-19 Kai-Uwe Kern Bromhexine for the treatment of pain
CA3129089A1 (en) 2019-03-11 2020-09-17 Bridget Mccarthy Cole Ester substituted ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10934263B2 (en) 2019-03-11 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
EP3937929A4 (en) 2019-03-11 2022-12-28 Nocion Therapeutics, Inc. CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
BR112022008575A2 (pt) 2019-11-06 2022-08-09 Nocion Therapeutics Inc Bloqueadores de canal iônico carregado e métodos para uso
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
WO2024105225A1 (en) 2022-11-18 2024-05-23 Universitat De Barcelona Synergistic combinations of a sigma receptor 1 (s1r) antagonist and a soluble epoxide hydrolase inhibitor (sehi) and their use in the treatment of pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4198299A (en) * 1998-05-21 1999-12-06 Rae R. Matsumoto Compounds and uses thereof
DE69941712D1 (de) * 1998-09-15 2010-01-07 Lilly Co Eli Verwendung von duloxetine zur behandlung von fibromyalgie
EP1138330A1 (en) * 1999-12-23 2001-10-04 Warner-Lambert Company Combination of trimebutine with an opioid analgesic
CA2479098A1 (en) * 2002-03-20 2003-09-25 Maree Therese Smith Methods and compositions comprising nitric oxide donors and opioid analgesics

Also Published As

Publication number Publication date
EP1781272B1 (en) 2017-09-06
CA2573122A1 (en) 2006-02-02
JP2008507489A (ja) 2008-03-13
WO2006010587A1 (en) 2006-02-02
EP1781272A1 (en) 2007-05-09
MX2007000793A (es) 2007-03-21
ES2651021T3 (es) 2018-01-23

Similar Documents

Publication Publication Date Title
PT1781272T (pt) Utilização de compostos ativos no recetor sigma para o tratamento de alodinia mecânica
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
PL2213168T3 (pl) Pestycydowe kombinacje substancji czynnych
ZA200705783B (en) Amino-imidazolones for the inhibition of ß-secretase
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
AP2007004157A0 (en) N- (N-sulfonylaminomethyl) cyclo-propanecarboxamide derivatives useful for the treatment of pain
HK1163672A1 (en) Processes for the preparation of compounds
IL177232A0 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
IL179462A0 (en) Use of the receptor gpr86
HK1203055A1 (en) Treatment for multiple sclerosis
PT1945243E (pt) Utilização da calcitonina para o tratamento da ar
EP1888056A4 (en) USE OF LADOSTIGIL FOR TREATING MULTIPLE SCLEROSIS
PL1811866T3 (pl) Zastosowanie związków przeciwutleniających przy uszkodzeniach mięśni
GB0402492D0 (en) Pharmaceutically active compounds
EP1750698A4 (en) 5-ANILINO-4-HETEROARYLPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES
IL177735A0 (en) Combined pharmaceutical composition for the inhibition of the decline of cognitive functions
GB0400802D0 (en) Compounds for the treatment of disease
HK1103006A1 (en) Medical plaster for application on the skin
IL178907A0 (en) Use of sulglicotide for the treatment of mucositis
EP1908467A4 (en) HERPESVIRUS DERIVED THERAPEUTIC AGENTS AGAINST PAIN
ZA200606780B (en) Compounds for the treatment of diseases
IL185691A0 (en) Novel compounds derived from 5-thioxylose and therapeutic use thereof
EP1900363A4 (en) THERAPEUTIC AGENT AGAINST PAIN
EP1944041A4 (en) THERAPEUTIC AGENT AGAINST NEUROGEN PAIN
ZA200608015B (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes